Remune (gp 120-depleted HIV-1) / Immune Response BioPharma - LARVOL DELTA

A Mixed-Methods Study Exploring the Feasibility of a Digital Combined Lifestyle Intervention for Patients With Post Covid-19 Condition. (PubMed, Health Expect) - "A digital personalised CLI was well-received among patients with PCC regarding compliance, experiences and perceived effectiveness. These findings will guide the development and implementation of tailored interventions to enhance overall well-being among patients with PCC."

Journal • Infectious Disease • Novel Coronavirus Disease

Developing a stimulation-free remote motor unit number estimate in Motor Neurone Disease (REMUNE) (ALS-MND 2024) - No abstract available

Amyotrophic Lateral Sclerosis

Developing a stimulation-free Remote Motor Unit Number Estimate (Remune) (ALS-MND 2023) - No abstract available

Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Cancer Cachexia (clinicaltrials.gov) - P1 | N=25 | Completed | Sponsor: University of Rochester | Active, not recruiting ➔ Completed | N=45 ➔ 25

Enrollment change • Trial completion • Biliary Tract Cancer • Cachexia • Cholangiocarcinoma • Gallbladder Cancer • Gastrointestinal Cancer • Gastrointestinal Disorder • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor

Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Cancer Cachexia (clinicaltrials.gov) - P1 | N=45 | Active, not recruiting | Sponsor: University of Rochester | Trial completion date: Dec 2023 ➔ Dec 2025

Trial completion date • Biliary Tract Cancer • Cachexia • Cholangiocarcinoma • Gallbladder Cancer • Gastrointestinal Cancer • Gastrointestinal Disorder • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor

Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Cancer Cachexia (clinicaltrials.gov) - P1 | N=45 | Active, not recruiting | Sponsor: University of Rochester | Recruiting ➔ Active, not recruiting | Trial completion date: Dec 2022 ➔ Dec 2023 | Trial primary completion date: Apr 2022 ➔ Apr 2023

Enrollment closed • Trial completion date • Trial primary completion date • Biliary Tract Cancer • Cachexia • Cholangiocarcinoma • Gallbladder Cancer • Gastrointestinal Cancer • Gastrointestinal Disorder • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor

Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Cancer Cachexia (clinicaltrials.gov) - P1; N=45; Recruiting; Sponsor: University of Rochester; Not yet recruiting ➔ Recruiting

Clinical • Enrollment open • Biliary Cancer • Cachexia • Cholangiocarcinoma • Gastrointestinal Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Thoracic Cancer

Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Cancer Cachexia (clinicaltrials.gov) - P1; N=45; Not yet recruiting; Sponsor: University of Rochester; Trial completion date: Jun 2022 ➔ Dec 2022; Trial primary completion date: Jun 2021 ➔ Apr 2022

Clinical • Trial completion date • Trial primary completion date

Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Cancer Cachexia (clinicaltrials.gov) - P1; N=45; Not yet recruiting; Sponsor: University of Rochester

Clinical • New P1 trial